Home › Funds › Nixon Capital, LLC › GENI
Nixon Capital, LLC position in GENI
GENIUS SPORTS LIMITED · Consumer Discretionary
Nixon Capital, LLC reported holding 1,680,143 shares of GENI (GENIUS SPORTS LIMITED) in its Q3 2026 13F filing — a position valued at US$9.6M, representing 3.19% of its reported portfolio and ranking #18 among its reported holdings. Nixon Capital, LLC has disclosed GENI holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Nixon Capital, LLC's GENI position evolved
Nixon Capital, LLC first disclosed a stake in GENI in Q4 2024 at 973,862 shares (US$8.5M). The position peaked in Q2 2026 at 2,842,205 shares, worth US$17.2M. Across 8 filings, Nixon Capital, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,680,143 shares valued at US$9.6M — a reduction of -1,162,062 shares quarter over quarter.. Notable position changes include a 203% increase in Q1 2026 (shares rose 37% over the following quarter), a 41% trim in Q3 2026 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 973.86K | $8.46M | New |
| Q1 2025 | 1.04M | $10.40M | Add |
| Q2 2025 | 1.03M | $10.67M | Reduce |
| Q3 2025 | 838.13K | $10.38M | Reduce |
| Q4 2025 | 840.66K | $9.26M | Hold |
| Q1 2026 | 2.55M | $11.29M | Add |
| Q2 2026 | 2.84M | $17.22M | Add |
| Q3 2026 | 1.68M | $9.63M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GENI and 13F data
GENI (GENIUS SPORTS LIMITED) is a Consumer Discretionary company. 22 other funds we track also report a position in GENI — the largest reported positions include Senvest Management, LLC (US$96.2M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$81.8M), SHAPIRO CAPITAL MANAGEMENT LLC (US$56.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GENI
- Senvest Management, LLC 15.88M sh · $96.24M · Q2 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 13.50M sh · $81.78M · Q2 2026
- SHAPIRO CAPITAL MANAGEMENT LLC 9.79M sh · $56.10M · Q3 2026
- DISCOVERY CAPITAL MANAGEMENT, LLC / CT 7.23M sh · $43.82M · Q2 2026
- Portolan Capital Management, LLC 7.03M sh · $42.58M · Q2 2026
- Granahan Investment Management, LLC 7.02M sh · $42.57M · Q2 2026
- Voss Capital, LP 6.85M sh · $41.51M · Q2 2026
- NEEDHAM INVESTMENT MANAGEMENT LLC 4.92M sh · $29.85M · Q2 2026
- Samjo Management, LLC 4.91M sh · $29.77M · Q2 2026
- CYPRESS POINT INVESTMENT MANAGEMENT LP 4.15M sh · $25.16M · Q2 2026
- IFC Advisors LLC 4.05M sh · $24.56M · Q2 2026
More on Nixon Capital, LLC
FAQ
How long has Nixon Capital, LLC held GENI?
Nixon Capital, LLC has disclosed GENI holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Nixon Capital, LLC's current position in GENI?
As of Q3 2026, Nixon Capital, LLC holds 1.68M shares of GENI (GENIUS SPORTS LIMITED), valued at $9.63M, representing 3.19% of its reported portfolio and ranking #18.
Has Nixon Capital, LLC been buying or selling GENI?
In the latest 13F filing (Q3 2026), Nixon Capital, LLC reduced its position in GENI. The position peaked in Q2 2026 at 2.84M shares.
Which other funds hold GENI?
Other major institutional holders of GENI include Senvest Management, LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, SHAPIRO CAPITAL MANAGEMENT LLC, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.